430 related articles for article (PubMed ID: 7505280)
21. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor binding protein (IGFBP)-3 levels in conditioned media of Hs578T human breast cancer cells are post-transcriptionally regulated.
Oh Y; Müller HL; Pham H; Lamson G; Rosenfeld RG
Growth Regul; 1993 Mar; 3(1):84-7. PubMed ID: 7683543
[TBL] [Abstract][Full Text] [Related]
23. A unique receptor-independent mechanism by which insulinlike growth factor I regulates the availability of insulinlike growth factor binding proteins in normal and transformed human fibroblasts.
Conover CA
J Clin Invest; 1991 Oct; 88(4):1354-61. PubMed ID: 1717510
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor binding protein (IGFBP) inhibits IGF action on human osteosarcoma cells.
Campbell PG; Novak JF
J Cell Physiol; 1991 Nov; 149(2):293-300. PubMed ID: 1721071
[TBL] [Abstract][Full Text] [Related]
25. Effects of insulin-like growth factor (IGF) binding proteins (BPs) -3 and -6 on DNA synthesis of rat osteoblasts: further evidence for a role of auto-/paracrine IGF I but not IGF II in stimulating osteoblast growth.
Schmid C; Schläpfer I; Keller A; Waldvogel M; Froesch ER; Zapf J
Biochem Biophys Res Commun; 1995 Jul; 212(1):242-8. PubMed ID: 7541985
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor binding protein (IGFBP-3), an inhibitor of serum growth factors other than IGF-I and -II.
Liu L; Delbé J; Blat C; Zapf J; Harel L
J Cell Physiol; 1992 Oct; 153(1):15-21. PubMed ID: 1381713
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol.
Martin JL; Coverley JA; Pattison ST; Baxter RC
Endocrinology; 1995 Mar; 136(3):1219-26. PubMed ID: 7532580
[TBL] [Abstract][Full Text] [Related]
28. Regulation of insulin-like growth factor (IGF) binding protein-2 synthesis and degradation by platelet-derived growth factor and the IGFs is enhanced by serum deprivation in vascular smooth muscle cells.
Cohick WS; Gockerman A; Clemmons DR
J Cell Physiol; 1995 Jul; 164(1):187-96. PubMed ID: 7540619
[TBL] [Abstract][Full Text] [Related]
29. Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation.
Park JH; Corkins MR; Vanderhoof JA; Caruso NM; Hrbek MJ; Schaffer BS; Slentz DH; McCusker RH; MacDonald RG
J Cell Physiol; 1996 Feb; 166(2):396-406. PubMed ID: 8592000
[TBL] [Abstract][Full Text] [Related]
30. IGF binding protein-3 secreted by the prostate adenocarcinoma cells (PC-3): differential effect on PC-3 and normal prostate cell growth.
Kaicer E; Blat C; Imbenotte J; Troalen F; Cussenot O; Calvo F; Harel L
Growth Regul; 1993 Sep; 3(3):180-9. PubMed ID: 7693099
[TBL] [Abstract][Full Text] [Related]
31. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
32. Regulation of insulin-like growth factor binding protein secretion by a murine mammary epithelial cell line.
Skaar TC; Baumrucker CR
Exp Cell Res; 1993 Dec; 209(2):183-8. PubMed ID: 7505235
[TBL] [Abstract][Full Text] [Related]
33. Regulation of insulin-like growth factor (IGF) binding protein-5 in the T47D human breast carcinoma cell line by IGF-I and retinoic acid.
Shemer J; Yaron A; Werner H; Shao ZM; Sheikh MS; Fontana JA; LeRoith D; Roberts CT
J Clin Endocrinol Metab; 1993 Nov; 77(5):1246-50. PubMed ID: 7521344
[TBL] [Abstract][Full Text] [Related]
34. IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma.
Shao ZM; Sheikh MS; Ordonez JV; Feng P; Kute T; Chen JC; Aisner S; Schnaper L; LeRoith D; Roberts CT
Cancer Res; 1992 Sep; 52(18):5100-3. PubMed ID: 1381277
[TBL] [Abstract][Full Text] [Related]
35. A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780.
Huynh H; Yang XF; Pollak M
Cell Growth Differ; 1996 Nov; 7(11):1501-6. PubMed ID: 8930399
[TBL] [Abstract][Full Text] [Related]
36. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
Arteaga CL; Osborne CK
Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250
[TBL] [Abstract][Full Text] [Related]
37. A factor contained in plasma is required for IGF binding protein-1 to potentiate the effect of IGF-I on smooth muscle cell DNA synthesis.
Clemmons DR; Gardner LI
J Cell Physiol; 1990 Oct; 145(1):129-35. PubMed ID: 1698793
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
39. Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells.
van der Burg B; Isbrücker L; van Selm-Miltenburg AJ; de Laat SW; van Zoelen EJ
Cancer Res; 1990 Dec; 50(24):7770-4. PubMed ID: 2174732
[TBL] [Abstract][Full Text] [Related]
40. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
